ID ILK_MOUSE Reviewed; 452 AA.
AC O55222; Q78KK2;
DT 01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT 31-OCT-2006, sequence version 2.
DT 04-NOV-2026, entry version 225.
DE RecName: Full=Scaffold protein ILK {ECO:0000305};
DE AltName: Full=ILK-1 {ECO:0000250|UniProtKB:Q13418};
DE AltName: Full=ILK-2 {ECO:0000250|UniProtKB:Q13418};
DE AltName: Full=Inactive integrin-linked kinase {ECO:0000305};
DE AltName: Full=p59ILK {ECO:0000250|UniProtKB:Q13418};
GN Name=Ilk {ECO:0000312|MGI:MGI:1195267};
GN Synonyms=ILK1 {ECO:0000250|UniProtKB:Q13418},
GN ILK2 {ECO:0000250|UniProtKB:Q13418};
OS Mus musculus (Mouse).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC Murinae; Mus; Mus.
OX NCBI_TaxID=10090;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RC STRAIN=BALB/cJ; TISSUE=Heart;
RX PubMed=9366252; DOI=10.1016/s0167-4889(97)00089-x;
RA Li F., Liu J., Mayne R., Wu C.;
RT "Identification and characterization of a mouse protein kinase that is
RT highly homologous to human integrin-linked kinase.";
RL Biochim. Biophys. Acta 1358:215-220(1997).
RN [2]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC STRAIN=FVB/N; TISSUE=Mammary tumor;
RX PubMed=15489334; DOI=10.1101/gr.2596504;
RG The MGC Project Team;
RT "The status, quality, and expansion of the NIH full-length cDNA project:
RT the Mammalian Gene Collection (MGC).";
RL Genome Res. 14:2121-2127(2004).
RN [3]
RP INTERACTION WITH TGFB1I1.
RX PubMed=16737959; DOI=10.1074/jbc.m513111200;
RA Mori K., Asakawa M., Hayashi M., Imura M., Ohki T., Hirao E.,
RA Kim-Kaneyama J.-R., Nose K., Shibanuma M.;
RT "Oligomerizing potential of a focal adhesion LIM protein Hic-5 organizing a
RT nuclear-cytoplasmic shuttling complex.";
RL J. Biol. Chem. 281:22048-22061(2006).
RN [4]
RP SUBCELLULAR LOCATION.
RX PubMed=18325335; DOI=10.1016/j.febslet.2008.01.064;
RA Matsuda C., Kameyama K., Suzuki A., Mishima W., Yamaji S., Okamoto H.,
RA Nishino I., Hayashi Y.K.;
RT "Affixin activates Rac1 via betaPIX in C2C12 myoblast.";
RL FEBS Lett. 582:1189-1196(2008).
RN [5]
RP SUBCELLULAR LOCATION, AND INTERACTION WITH FERMT2.
RX PubMed=18483218; DOI=10.1101/gad.469408;
RA Montanez E., Ussar S., Schifferer M., Bosl M., Zent R., Moser M.,
RA Fassler R.;
RT "Kindlin-2 controls bidirectional signaling of integrins.";
RL Genes Dev. 22:1325-1330(2008).
RN [6]
RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas,
RC Spleen, and Testis;
RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL Cell 143:1174-1189(2010).
RN [7]
RP FUNCTION, INTERACTION WITH IQGAP1, AND DISRUPTION PHENOTYPE.
RX PubMed=20951348; DOI=10.1016/j.devcel.2010.09.007;
RA Wickstroem S.A., Lange A., Hess M.W., Polleux J., Spatz J.P., Krueger M.,
RA Pfaller K., Lambacher A., Bloch W., Mann M., Huber L.A., Faessler R.;
RT "Integrin-linked kinase controls microtubule dynamics required for plasma
RT membrane targeting of caveolae.";
RL Dev. Cell 19:574-588(2010).
RN [8]
RP ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-426, AND IDENTIFICATION BY MASS
RP SPECTROMETRY [LARGE SCALE ANALYSIS].
RC TISSUE=Embryonic fibroblast;
RX PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,
RA Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT pathways.";
RL Mol. Cell 50:919-930(2013).
CC -!- FUNCTION: Scaffold protein which mediates protein-protein interactions
CC during a range of cellular events including focal adhesion assembly,
CC cell adhesion and cell migration (By similarity). Regulates integrin-
CC mediated signal transduction by contributing to inside-out integrin
CC activation (By similarity). Recruits PARVA and LIMS1/PITCH to form the
CC heterotrimeric IPP (ILK-PINCH-PARVIN) complex which binds to F-actin
CC via the C-terminal tail of LIMS1 and the N-terminal region of PARVA,
CC promoting F-actin filament bundling, a process required to generate
CC force for actin cytoskeleton reorganization and subsequent dynamic cell
CC adhesion events such as cell spreading and migration (By similarity).
CC Binding to PARVA promotes effective assembly of ILK into focal
CC adhesions while PARVA-bound ILK can simultaneously engage integrin-beta
CC cytoplasmic tails to mediate cell adhesion (By similarity). Plays a
CC role with PARVG in promoting the cell adhesion and spreading of
CC leukocytes (By similarity). Acts as an upstream effector of both
CC AKT1/PKB and GSK3 (By similarity). Mediates trafficking of caveolae to
CC the cell surface in an ITGB1-dependent manner by promoting the
CC recruitment of IQGAP1 to the cell cortex which cooperates with its
CC effector DIAPH1 to locally stabilize microtubules and allow stable
CC insertion of caveolae into the plasma membrane (PubMed:20951348).
CC Required for the maintenance of mitotic spindle integrity by promoting
CC phosphorylation of TACC3 by AURKA (By similarity). Associates with
CC chromatin and may act as a negative regulator of transcription when
CC located in the nucleus (By similarity). {ECO:0000250|UniProtKB:Q13418,
CC ECO:0000250|UniProtKB:Q99J82, ECO:0000269|PubMed:20951348}.
CC -!- SUBUNIT: Component of the heterotrimeric IPP (ILK-PINCH-PARVIN) complex
CC composed of ILK, LIMS1/PINCH and PARVA; the complex binds to F-actin
CC via the C-terminal tail of LIMS1 and the N-terminal region of PARVA,
CC promoting F-actin filament bundling (By similarity). Formation of the
CC IPP complex is dependent on protein kinase C and precedes integrin-
CC mediated cell adhesion and spreading (By similarity). ILK also
CC interacts with LIMS2/PINCH2 and with PARVB and PARVG which may
CC substitute for LIMS1 and PARVA in the IPP complex; PARVA and PARVB
CC compete for the same binding site (By similarity). Interaction with
CC PARVG promotes the establishment of cell polarity required for
CC leukocyte migration (By similarity). Interacts with the cytoplasmic
CC domain of integrin ITGB1 and may also interact with integrins ITGB2,
CC ITGB3 and/or ITGB5 (By similarity). Interacts probably also with
CC TGFB1I1 (PubMed:16737959). Interacts (via ANK repeats) with EPHA1 (via
CC SAM domain); stimulated by EFNA1 but independent of the kinase activity
CC of EPHA1 (By similarity). Interacts with FERMT2 (PubMed:18483218).
CC Interacts with LIMD2; leading to activate the protein kinase activity
CC (By similarity). Interacts with PXN/PAXILLIN (via LD motif 4) (By
CC similarity). Interacts with CCDC25 (via cytoplasmic region); initiating
CC the ILK-PARVB cascade to induce cytoskeleton rearrangement and
CC directional migration of cells (By similarity). Interacts with IQGAP1;
CC the interaction is required for localization of IQGAP1 to the cell
CC cortex (PubMed:20951348). {ECO:0000250|UniProtKB:Q13418,
CC ECO:0000269|PubMed:16737959, ECO:0000269|PubMed:18483218,
CC ECO:0000269|PubMed:20951348}.
CC -!- INTERACTION:
CC O55222; Q9EPC1: Parva; NbExp=7; IntAct=EBI-6690138, EBI-6690233;
CC O55222; Q9ES46: Parvb; NbExp=3; IntAct=EBI-6690138, EBI-6914996;
CC O55222; Q9WUD1: Stub1; NbExp=7; IntAct=EBI-6690138, EBI-773027;
CC O55222; P48059: LIMS1; Xeno; NbExp=4; IntAct=EBI-6690138, EBI-306928;
CC O55222; Q9NVD7: PARVA; Xeno; NbExp=2; IntAct=EBI-6690138, EBI-747655;
CC -!- SUBCELLULAR LOCATION: Cell junction, focal adhesion
CC {ECO:0000269|PubMed:18325335, ECO:0000269|PubMed:18483218}. Cell
CC membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250};
CC Cytoplasmic side {ECO:0000250|UniProtKB:Q13418}. Cytoplasm, myofibril,
CC sarcomere {ECO:0000250|UniProtKB:Q13418}. Cell projection,
CC lamellipodium {ECO:0000269|PubMed:18325335}. Cytoplasm
CC {ECO:0000250|UniProtKB:Q13418}. Nucleus {ECO:0000250|UniProtKB:Q13418}.
CC Cytoplasm, cytoskeleton, microtubule organizing center, centrosome
CC {ECO:0000250|UniProtKB:Q13418}. Cytoplasm, cell cortex
CC {ECO:0000250|UniProtKB:Q13418}.
CC -!- TISSUE SPECIFICITY: Highly expressed in lung, heart, kidney, liver,
CC brain, spleen and skeletal muscle. Weakly expressed in testis.
CC -!- DOMAIN: The kinase domain is likely to have lost catalytic activity but
CC retains ATP-binding activity. ATP structurally stabilizes the kinase
CC domain and promotes stability of binding to PARVA as well as focal
CC adhesion stability. {ECO:0000250|UniProtKB:Q13418}.
CC -!- DOMAIN: The PH-like region is not required for assembly of the IPP
CC complex or for localization of ILK to focal adhesions.
CC {ECO:0000250|UniProtKB:Q13418}.
CC -!- PTM: Phosphorylation by PAK1 modulates ILK subcellular location by
CC promoting its nuclear export. {ECO:0000250|UniProtKB:Q13418}.
CC -!- DISRUPTION PHENOTYPE: Conditional knockout in keratinocytes results in
CC a dramatically reduced number of caveolae at the basal plasma membrane
CC with abnormal localization of Cav1 throughout the cytoplasm.
CC {ECO:0000269|PubMed:20951348}.
CC -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC protein kinase family. {ECO:0000305}.
CC -!- CAUTION: Was originally thought to act as a serine/threonine-protein
CC kinase. Now thought to be a pseudokinase which does not have kinase
CC activity and which functions solely as a scaffold protein.
CC {ECO:0000250|UniProtKB:Q13418}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; U94479; AAB94646.1; -; mRNA.
DR EMBL; BC003737; AAH03737.1; -; mRNA.
DR CCDS; CCDS21659.1; -.
DR RefSeq; NP_001155196.1; NM_001161724.1.
DR RefSeq; NP_034692.2; NM_010562.2.
DR AlphaFoldDB; O55222; -.
DR BMRB; O55222; -.
DR SMR; O55222; -.
DR BioGRID; 200649; 18.
DR CORUM; O55222; -.
DR DIP; DIP-41971N; -.
DR FunCoup; O55222; 1975.
DR IntAct; O55222; 49.
DR STRING; 10090.ENSMUSP00000033182; -.
DR GlyGen; O55222; 1 site, 1 O-linked glycan (1 site).
DR iPTMnet; O55222; -.
DR PhosphoSitePlus; O55222; -.
DR SwissPalm; O55222; -.
DR jPOST; O55222; -.
DR PaxDb; 10090-ENSMUSP00000033182; -.
DR PeptideAtlas; O55222; -.
DR ProteomicsDB; 269477; -.
DR Pumba; O55222; -.
DR Antibodypedia; 23909; 961 antibodies from 47 providers.
DR DNASU; 16202; -.
DR Ensembl; ENSMPUT00000005545; ENSMPUP00000005454; ENSMPUG00000005495.
DR Ensembl; ENSMUST00000033182.10; ENSMUSP00000033182.4; ENSMUSG00000030890.17.
DR Ensembl; ENSMUST00000163389.9; ENSMUSP00000130341.2; ENSMUSG00000030890.17.
DR GeneID; 16202; -.
DR KEGG; mmu:16202; -.
DR UCSC; uc009izb.2; mouse.
DR AGR; MGI:1195267; -.
DR CTD; 3611; -.
DR MGI; MGI:1195267; Ilk.
DR VEuPathDB; HostDB:ENSMUSG00000030890; -.
DR eggNOG; KOG0195; Eukaryota.
DR GeneTree; ENSGT00940000155956; -.
DR HOGENOM; CLU_000288_7_5_1; -.
DR InParanoid; O55222; -.
DR OMA; AAKYGQY; -.
DR OrthoDB; 6718656at2759; -.
DR PhylomeDB; O55222; -.
DR BRENDA; 2.7.10.2; 3474.
DR Reactome; R-MMU-446343; Localization of the PINCH-ILK-PARVIN complex to focal adhesions.
DR Reactome; R-MMU-446353; Cell-extracellular matrix interactions.
DR BioGRID-ORCS; 16202; 13 hits in 83 CRISPR screens.
DR PRO; PR:O55222; -.
DR Proteomes; UP000000589; Chromosome 7.
DR RNAct; O55222; protein.
DR Bgee; ENSMUSG00000030890; Expressed in placenta labyrinth and 275 other cell types or tissues.
DR ExpressionAtlas; O55222; baseline and differential.
DR GO; GO:0015629; C:actin cytoskeleton; ISO:GO_Central.
DR GO; GO:0030424; C:axon; ISO:GO_Central.
DR GO; GO:0005938; C:cell cortex; IEA:UniProtKB-SubCell.
DR GO; GO:0005911; C:cell-cell junction; ISO:GO_Central.
DR GO; GO:0005813; C:centrosome; ISO:GO_Central.
DR GO; GO:0000785; C:chromatin; ISS:UniProtKB.
DR GO; GO:0043034; C:costamere; ISO:GO_Central.
DR GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR GO; GO:0005829; C:cytosol; ISO:GO_Central.
DR GO; GO:0043198; C:dendritic shaft; ISO:GO_Central.
DR GO; GO:0005925; C:focal adhesion; IDA:MGI.
DR GO; GO:0030027; C:lamellipodium; IDA:UniProtKB.
DR GO; GO:0043025; C:neuronal cell body; ISO:GO_Central.
DR GO; GO:0005654; C:nucleoplasm; ISO:GO_Central.
DR GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR GO; GO:0005886; C:plasma membrane; ISO:GO_Central.
DR GO; GO:0032991; C:protein-containing complex; ISO:GO_Central.
DR GO; GO:0030017; C:sarcomere; IEA:UniProtKB-SubCell.
DR GO; GO:0001725; C:stress fiber; ISO:GO_Central.
DR GO; GO:0043195; C:terminal bouton; ISO:GO_Central.
DR GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR GO; GO:0005178; F:integrin binding; ISS:UniProtKB.
DR GO; GO:0000287; F:magnesium ion binding; ISS:UniProtKB.
DR GO; GO:0019904; F:protein domain specific binding; ISO:GO_Central.
DR GO; GO:0004672; F:protein kinase activity; ISO:GO_Central.
DR GO; GO:0019901; F:protein kinase binding; ISO:GO_Central.
DR GO; GO:0044877; F:protein-containing complex binding; ISO:GO_Central.
DR GO; GO:0030674; F:protein-macromolecule adaptor activity; IBA:GO_Central.
DR GO; GO:0017124; F:SH3 domain binding; ISO:GO_Central.
DR GO; GO:0005102; F:signaling receptor binding; IBA:GO_Central.
DR GO; GO:0051017; P:actin filament bundle assembly; ISO:GO_Central.
DR GO; GO:0051639; P:actin filament network formation; ISO:GO_Central.
DR GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; IDA:MGI.
DR GO; GO:0070836; P:caveola assembly; IMP:UniProtKB.
DR GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR GO; GO:0000902; P:cell morphogenesis; ISO:GO_Central.
DR GO; GO:0007160; P:cell-matrix adhesion; IBA:GO_Central.
DR GO; GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; IMP:MGI.
DR GO; GO:0010761; P:fibroblast migration; IMP:MGI.
DR GO; GO:0007229; P:integrin-mediated signaling pathway; IMP:BHF-UCL.
DR GO; GO:0007052; P:mitotic spindle organization; ISO:GO_Central.
DR GO; GO:0022011; P:myelination in peripheral nervous system; IMP:MGI.
DR GO; GO:0043066; P:negative regulation of apoptotic process; ISO:GO_Central.
DR GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; ISO:GO_Central.
DR GO; GO:2000178; P:negative regulation of neural precursor cell proliferation; IMP:MGI.
DR GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISO:GO_Central.
DR GO; GO:0006469; P:negative regulation of protein kinase activity; ISO:GO_Central.
DR GO; GO:0014912; P:negative regulation of smooth muscle cell migration; ISO:GO_Central.
DR GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; ISO:GO_Central.
DR GO; GO:0021675; P:nerve development; IMP:MGI.
DR GO; GO:0048812; P:neuron projection morphogenesis; ISO:GO_Central.
DR GO; GO:0003151; P:outflow tract morphogenesis; IMP:CACAO.
DR GO; GO:0018105; P:peptidyl-serine phosphorylation; IMP:MGI.
DR GO; GO:0043491; P:phosphatidylinositol 3-kinase/protein kinase B signal transduction; IMP:MGI.
DR GO; GO:0045773; P:positive regulation of axon extension; ISO:GO_Central.
DR GO; GO:0050772; P:positive regulation of axonogenesis; ISO:GO_Central.
DR GO; GO:0030513; P:positive regulation of BMP signaling pathway; IMP:BHF-UCL.
DR GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; ISO:GO_Central.
DR GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; ISO:GO_Central.
DR GO; GO:0030335; P:positive regulation of cell migration; ISO:GO_Central.
DR GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:MGI.
DR GO; GO:0001954; P:positive regulation of cell-matrix adhesion; ISO:GO_Central.
DR GO; GO:2000774; P:positive regulation of cellular senescence; ISO:GO_Central.
DR GO; GO:0050775; P:positive regulation of dendrite morphogenesis; ISO:GO_Central.
DR GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:GO_Central.
DR GO; GO:0043406; P:positive regulation of MAP kinase activity; ISO:GO_Central.
DR GO; GO:0043410; P:positive regulation of MAPK cascade; ISO:GO_Central.
DR GO; GO:0045663; P:positive regulation of myoblast differentiation; ISO:GO_Central.
DR GO; GO:0045669; P:positive regulation of osteoblast differentiation; IMP:BHF-UCL.
DR GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:GO_Central.
DR GO; GO:0009967; P:positive regulation of signal transduction; ISO:GO_Central.
DR GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; ISO:GO_Central.
DR GO; GO:0072697; P:protein localization to cell cortex; IMP:UniProtKB.
DR GO; GO:0006468; P:protein phosphorylation; ISO:GO_Central.
DR GO; GO:0032956; P:regulation of actin cytoskeleton organization; ISO:GO_Central.
DR GO; GO:0001558; P:regulation of cell growth; ISO:GO_Central.
DR GO; GO:0014044; P:Schwann cell development; IMP:MGI.
DR GO; GO:0034446; P:substrate adhesion-dependent cell spreading; ISO:GO_Central.
DR GO; GO:0097435; P:supramolecular fiber organization; ISO:GO_Central.
DR GO; GO:0033209; P:tumor necrosis factor-mediated signaling pathway; ISO:GO_Central.
DR CDD; cd14057; PK_ILK; 1.
DR FunFam; 3.30.200.20:FF:000245; Integrin-linked protein kinase; 1.
DR FunFam; 1.10.510.10:FF:000187; integrin-linked protein kinase; 1.
DR FunFam; 1.25.40.20:FF:000050; integrin-linked protein kinase; 1.
DR Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 1.
DR Gene3D; 3.30.200.20; Phosphorylase Kinase, domain 1; 1.
DR Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR InterPro; IPR002110; Ankyrin_rpt.
DR InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR InterPro; IPR011009; Kinase-like_dom_sf.
DR InterPro; IPR035692; PK_ILK.
DR InterPro; IPR000719; Prot_kinase_dom.
DR InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR InterPro; IPR051681; Ser/Thr_Kinases-Pseudokinases.
DR PANTHER; PTHR44329:SF57; INTEGRIN-LINKED PROTEIN KINASE; 1.
DR PANTHER; PTHR44329; SERINE/THREONINE-PROTEIN KINASE TNNI3K-RELATED; 1.
DR Pfam; PF12796; Ank_2; 1.
DR Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR PIRSF; PIRSF000654; Integrin-linked_kinase; 1.
DR SMART; SM00248; ANK; 3.
DR SUPFAM; SSF48403; Ankyrin repeat; 1.
DR SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR PROSITE; PS50297; ANK_REP_REGION; 1.
DR PROSITE; PS50088; ANK_REPEAT; 3.
DR PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE 1: Evidence at protein level;
KW Acetylation; ANK repeat; ATP-binding; Cell junction; Cell membrane;
KW Cell projection; Cytoplasm; Cytoskeleton; Magnesium; Membrane;
KW Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW Reference proteome; Repeat.
FT CHAIN 1..452
FT /note="Scaffold protein ILK"
FT /id="PRO_0000086022"
FT REPEAT 2..30
FT /note="ANK 1"
FT /evidence="ECO:0000250|UniProtKB:Q13418"
FT REPEAT 31..63
FT /note="ANK 2"
FT /evidence="ECO:0000250|UniProtKB:Q13418"
FT REPEAT 64..96
FT /note="ANK 3"
FT /evidence="ECO:0000250|UniProtKB:Q13418"
FT REPEAT 97..129
FT /note="ANK 4"
FT /evidence="ECO:0000250|UniProtKB:Q13418"
FT REPEAT 130..174
FT /note="ANK 5"
FT /evidence="ECO:0000250|UniProtKB:Q13418"
FT DOMAIN 193..446
FT /note="Protein kinase"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT REGION 33..139
FT /note="Interaction with LIMS1"
FT /evidence="ECO:0000250|UniProtKB:Q13418"
FT REGION 180..212
FT /note="PH-like; mediates interaction with TGFB1I1"
FT /evidence="ECO:0000269|PubMed:16737959"
FT MOTIF 363..371
FT /note="Nuclear localization signal"
FT /evidence="ECO:0000250|UniProtKB:Q13418"
FT BINDING 200
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000250|UniProtKB:Q13418"
FT BINDING 202
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000250|UniProtKB:Q13418"
FT BINDING 203
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000250|UniProtKB:Q13418"
FT BINDING 204
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000250|UniProtKB:Q13418"
FT BINDING 270
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000250|UniProtKB:Q13418"
FT BINDING 272
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000250|UniProtKB:Q13418"
FT BINDING 279
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000250|UniProtKB:Q13418"
FT BINDING 339
FT /ligand="Mg(2+)"
FT /ligand_id="ChEBI:CHEBI:18420"
FT /evidence="ECO:0000250|UniProtKB:Q13418"
FT BINDING 341
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000250|UniProtKB:Q13418"
FT MOD_RES 1
FT /note="N-acetylmethionine"
FT /evidence="ECO:0000250|UniProtKB:Q13418"
FT MOD_RES 173
FT /note="Phosphothreonine"
FT /evidence="ECO:0000250|UniProtKB:Q13418"
FT MOD_RES 186
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:Q13418"
FT MOD_RES 246
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:Q13418"
FT MOD_RES 426
FT /note="N6-acetyllysine"
FT /evidence="ECO:0007744|PubMed:23806337"
FT CONFLICT 93
FT /note="I -> T (in Ref. 1; AAB94646)"
FT /evidence="ECO:0000305"
FT CONFLICT 413
FT /note="I -> V (in Ref. 1; AAB94646)"
FT /evidence="ECO:0000305"
SQ SEQUENCE 452 AA; 51373 MW; F41960CF8EC503A7 CRC64;
MDDIFTQCRE GNAVAVRLWL DNTENDLNQG DDHGFSPLHW ACREGRSAVV EMLIMRGARI
NVMNRGDDTP LHLAASHGHR DIVQKLLQYK ADINAVNEHG NVPLHYACFW GQDQVAEDLV
ANGALVSICN KYGEMPVDKA KAPLRELLRE RAEKMGQNLN RIPYKDTFWK GTTRTRPRNG
TLNKHSGIDF KQLNFLAKLN ENHSGELWKG RWQGNDIVVK VLKVRDWSTR KSRDFNEECP
RLRIFSHPNV LPVLGACQAP PAPHPTLITH WMPYGSLYNV LHEGTNFVVD QSQAVKFALD
MARGMAFLHT LEPLIPRHAL NSRSVMIDED MTARISMADV KFSFQCPGRM YAPAWVAPEA
LQKKPEDTNR RSADMWSFAV LLWELVTREV PFADLSNMEI GMKVALEGLR PTIPPGISPH
VCKLMKICMN EDPAKRPKFD MIVPILEKMQ DK
//